COVID-19 Vaccine Janssen - Important Safety Information from Janssen Sciences Ireland UC as approved by the HPRA (13.10.21)

Notice type: 3rd Party Publications

Date: 15/10/2021




Problem Or Issue:

Important Safety Information from Janssen Sciences Ireland UC regarding COVID-19 Vaccine Janssen: Risk for immune thrombocytopenia (ITP) and venous thromboembolism

 

Important Safety Information – COVID-19 Vaccine Janssen


« Back